Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.’ Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Cardillo, Giuseppe, Mokhles, Sahar, Williams, Norman, Macbeth, Fergus, Russell, Christopher, Treasure, TomVolume:
113
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2015.331
Date:
December, 2015
File:
PDF, 119 KB
english, 2015